InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,447.87
(
-0.31%
)
US TECH 100
18,978.00
(
-1.19%
)
Dow Jones
39,411.21
(
0.67%
)
Brent Oil
85.19
(
-0.10%
)
Bitcoin
61,344.56
(
1.80%
)
Post# of 252337
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biocqr

Send PM Follow Ignore
Followers 49
Posts 3516
Boards Moderated 0
Alias Born 08/24/2005

biocqr

Member Level

Re: DewDiligence post# 198763

Friday, 01/08/2016 12:20:53 PM

Friday, January 08, 2016 12:20:53 PM

Post# of 252337
ADXS > Advaxis Provides 2016 Business Outlook

11 Trials Evaluating Lm Technology™ Advance to Hit Multiple Development Milestones

PD-1 and PD-L1 Checkpoint Combination Trials Advance to Second Phases of Evaluation

Phase 3 AIM2CERV Trial to Commence in mid-2016

MINE™ (My Immunotherapy Neo-Epitopes) Progresses to Clinical Evaluation

http://ir.advaxis.com/press-releases/detail/1196
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up